Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1988 | 12-1987 | 09-1987 | 06-1987 | 03-1987 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,784 | 3,865 | 1,236 | 1,891 | 111 |
| Marketable Securities | 2,143 | 2,922 | 6,003 | 5,057 | 7,210 |
| Receivables | 764 | 733 | 690 | 1,148 | 439 |
| Inventories | 459 | 437 | 435 | 445 | 470 |
| Other current assets | 157 | 209 | 217 | 55 | 184 |
| TOTAL | $8,306 | $8,167 | $8,581 | $8,596 | $8,415 |
| Non-Current Assets | |||||
| PPE Net | 4,546 | 4,503 | 4,384 | 4,004 | 3,710 |
| Other Non-Current Assets | 1,697 | 1,772 | 1,847 | 1,824 | 1,960 |
| TOTAL | $6,243 | $6,275 | $6,231 | $5,829 | $5,670 |
| Total Assets | $14,055 | $14,036 | $14,489 | $14,127 | $13,875 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 217 | 423 | 445 | 188 | 626 |
| Accrued Expenses | 137 | 109 | 78 | 103 | 21 |
| Other current liabilities | 0 | 15 | 200 | 318 | 273 |
| TOTAL | $423 | $609 | $821 | $713 | $983 |
| Non-Current Liabilities | |||||
| TOTAL | $214 | $190 | $168 | $40 | $22 |
| Total Liabilities | $637 | $798 | $989 | $753 | $1,005 |
| Shareholders' Equity | |||||
| Common Shares | 29 | 29 | 30 | 30 | 30 |
| Retained earnings | 3,206 | 3,027 | 2,997 | 2,871 | 2,373 |
| TOTAL | $13,417 | $13,238 | $13,500 | $13,374 | $12,870 |
| Total Liabilities And Equity | $14,054 | $14,036 | $14,489 | $14,127 | $13,875 |